Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2009

01.02.2009

Crosstalk of Liver, Bile Ducts and the Gut

verfasst von: Ulrich Beuers

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

A complex interplay of liver, bile ducts, and the gut critically determines functioning of these organs in health and disease. Biochemical and physiological aspects of their interaction and the role of inflammatory cells, cytokines, bile acids, visceral hormones, neuropeptides and other messengers in the pathogenesis of model immune-mediated hepatobiliary disorders are discussed in the actual issue of Clinical Reviews in Allergy and Immunology. Potential molecular targets for future therapeutic approaches are also addressed.
Literatur
1.
Zurück zum Zitat Beuers U, Boyer JL (1994) Bile—a historical review of studies on its form and function. In: Kirsner JB (ed) Gastroenterology in the 20th century. Lea & Ferbiger, New York, pp 267–288 Beuers U, Boyer JL (1994) Bile—a historical review of studies on its form and function. In: Kirsner JB (ed) Gastroenterology in the 20th century. Lea & Ferbiger, New York, pp 267–288
2.
Zurück zum Zitat Hofmann AF (2007) Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 6(1):15–27PubMed Hofmann AF (2007) Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 6(1):15–27PubMed
3.
Zurück zum Zitat Jones S (2008) Mini-review: endocrine actions of fibroblast growth factor 19. Mol Pharmacol 5:42–48CrossRef Jones S (2008) Mini-review: endocrine actions of fibroblast growth factor 19. Mol Pharmacol 5:42–48CrossRef
5.
Zurück zum Zitat Alvaro D, Mancino MG, Glaser S et al (2007) Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132(1):415–431PubMedCrossRef Alvaro D, Mancino MG, Glaser S et al (2007) Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132(1):415–431PubMedCrossRef
6.
Zurück zum Zitat Marzioni M, Fava G, Alvaro D, Alpini G, Benedetti A (2008) Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides. Clin Rev Allergy Immunol doi:10.1007/s12016-008-8090-1 Marzioni M, Fava G, Alvaro D, Alpini G, Benedetti A (2008) Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides. Clin Rev Allergy Immunol doi:10.​1007/​s12016-008-8090-1
7.
Zurück zum Zitat Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47(2):737–745PubMedCrossRef Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47(2):737–745PubMedCrossRef
10.
Zurück zum Zitat LaRusso NF, Shneider BL, Black D et al (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44(3):746–764PubMedCrossRef LaRusso NF, Shneider BL, Black D et al (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44(3):746–764PubMedCrossRef
11.
Zurück zum Zitat Adams DH, Eksteen B (2006) Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 6(3):244–251PubMedCrossRef Adams DH, Eksteen B (2006) Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 6(3):244–251PubMedCrossRef
13.
Zurück zum Zitat Cullen SN, Rust C, Fleming K, Edwards C, Beuers U, Chapman R (2008) High dose ursodeoxycholic acid for the treatment of primary sclerosig cholangitis is safe and effective. J Hepatol 48:792–800PubMedCrossRef Cullen SN, Rust C, Fleming K, Edwards C, Beuers U, Chapman R (2008) High dose ursodeoxycholic acid for the treatment of primary sclerosig cholangitis is safe and effective. J Hepatol 48:792–800PubMedCrossRef
14.
Zurück zum Zitat Beuers U, Kullak-Ublick GA, Pusl T, Rauws ER, Rust C (2008) Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? Clin Rev Allergy Immunol doi:10.1007/s12016-008-8085-y Beuers U, Kullak-Ublick GA, Pusl T, Rauws ER, Rust C (2008) Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? Clin Rev Allergy Immunol doi:10.​1007/​s12016-008-8085-y
16.
Zurück zum Zitat Zollner G, Marschall HU, Wagner M, Trauner M (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharmacol 3(3):231–251CrossRef Zollner G, Marschall HU, Wagner M, Trauner M (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharmacol 3(3):231–251CrossRef
17.
Zurück zum Zitat Paumgartner G, Pusl T (2008) Medical treatment of cholestatic liver disease. Clin Liver Dis 12(1):53–80PubMedCrossRef Paumgartner G, Pusl T (2008) Medical treatment of cholestatic liver disease. Clin Liver Dis 12(1):53–80PubMedCrossRef
18.
Zurück zum Zitat Zhou ZH, Tzioufas AG, Notkins AL (2007) Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29:219–228PubMedCrossRef Zhou ZH, Tzioufas AG, Notkins AL (2007) Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29:219–228PubMedCrossRef
19.
Zurück zum Zitat Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309PubMedCrossRef Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309PubMedCrossRef
20.
Zurück zum Zitat Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249PubMedCrossRef Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249PubMedCrossRef
21.
Zurück zum Zitat Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205PubMedCrossRef Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205PubMedCrossRef
22.
Zurück zum Zitat Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212PubMedCrossRef Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212PubMedCrossRef
23.
Zurück zum Zitat Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261PubMedCrossRef Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261PubMedCrossRef
24.
Zurück zum Zitat Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245PubMedCrossRef Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245PubMedCrossRef
25.
Zurück zum Zitat Lan RY, Mackay IR, Gershwin ME (2007) Regulatory T cells in the prevention of mucosal inflammatory disease: patrolling the border. J Autoimmun 29:272–280PubMedCrossRef Lan RY, Mackay IR, Gershwin ME (2007) Regulatory T cells in the prevention of mucosal inflammatory disease: patrolling the border. J Autoimmun 29:272–280PubMedCrossRef
26.
Zurück zum Zitat Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29:213–218PubMedCrossRef Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29:213–218PubMedCrossRef
Metadaten
Titel
Crosstalk of Liver, Bile Ducts and the Gut
verfasst von
Ulrich Beuers
Publikationsdatum
01.02.2009
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2009
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-008-8084-z

Weitere Artikel der Ausgabe 1/2009

Clinical Reviews in Allergy & Immunology 1/2009 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.